2022 STS Annual Meeting Online: Implications and Management of Multiple Primary Cancers

As healthcare and cancer treatments improve physicians are tasked with managing more patients with multiple malignancies. This session is designed to add a better understanding of integrating management of multiple malignancies. Topics include patients presenting with multiple primary lung cancers as well as patients with other primary malignancies who then develop primary lung cancers. Discussions will include analysis of outcomes of one malignancy and when that should or should not influence the management of a secondary malignancy, namely Lung Cancer. The session will include concepts on differentiating patients undergoing treatment for one malignancy who have pulmonary nodule suspicious for metastatic disease or a primary lung neoplasm.

Learning Objectives

  • Differentiate terminology and care of patients with multiple primary lung cancers.
  • Understand survival curves of one malignancy and how that point of time should influence of care of newly identified malignancy.
  • Determine appropriate staging and subsequent management of patients with multiple primary lung cancers.

*Unless otherwise noted, speakers have nothing to disclose.

Presentations

  1. Incidence and Epidemiology of MPLC
    Presenter: Thomas Fabian, MD
Activity summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit
  • 0.25 Participation
Activity opens: 
03/01/2022
Activity expires: 
03/01/2025
Cost:
$0.00
Rating: 
0

Available Credit

  • 0.25 AMA PRA Category 1 Credit
  • 0.25 Participation

Price

Cost:
$0.00
Please login or register to take this course.

 

As healthcare and cancer treatments improve physicians are tasked with managing more patients with multiple malignancies. This session is designed to add a better understanding of integrating management of multiple malignancies. Topics include patients presenting with multiple primary lung cancers as well as patients with other primary malignancies who then develop primary lung cancers. Discussions will include analysis of outcomes of one malignancy and when that should or should not influence the management of a secondary malignancy, namely Lung Cancer. The session will include concepts on differentiating patients undergoing treatment for one malignancy who have pulmonary nodule suspicious for metastatic disease or a primary lung neoplasm.

Learning Objectives

  • Differentiate terminology and care of patients with multiple primary lung cancers.
  • Understand survival curves of one malignancy and how that point of time should influence of care of newly identified malignancy.
  • Determine appropriate staging and subsequent management of patients with multiple primary lung cancers.

*Unless otherwise noted, speakers have nothing to disclose.

Presentations

  1. Incidence and Epidemiology of MPLC
    Presenter: Thomas Fabian, MD